Bisphosphonates and Osteonecrosis of the Jaw: A Multidisciplinary Approach

Bisphosphonates are commonly prescribed to inhibit bone loss in patients with osteoporosis, as well as osteopenia, cancer, and Paget's disease of the bone. Recently, scientific literature has addressed a possible relationship between bisphosphonates and osteonecrosis of the jaw (ONJ). It is imp...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Συγγραφή απο Οργανισμό/Αρχή: SpringerLink (Online service)
Άλλοι συγγραφείς: De Ponte, Francesco Saverio (Επιμελητής έκδοσης)
Μορφή: Ηλεκτρονική πηγή Ηλ. βιβλίο
Γλώσσα:English
Έκδοση: Milano : Springer Milan, 2012.
Θέματα:
Διαθέσιμο Online:Full Text via HEAL-Link
LEADER 02791nam a22005295i 4500
001 978-88-470-2083-2
003 DE-He213
005 20151204145223.0
007 cr nn 008mamaa
008 111124s2012 it | s |||| 0|eng d
020 |a 9788847020832  |9 978-88-470-2083-2 
024 7 |a 10.1007/978-88-470-2083-2  |2 doi 
040 |d GrThAP 
050 4 |a RK529-535 
072 7 |a MMDS  |2 bicssc 
072 7 |a MED085020  |2 bisacsh 
082 0 4 |a 617.522059  |2 23 
245 1 0 |a Bisphosphonates and Osteonecrosis of the Jaw: A Multidisciplinary Approach  |h [electronic resource] /  |c edited by Francesco Saverio De Ponte. 
264 1 |a Milano :  |b Springer Milan,  |c 2012. 
300 |a XIII, 181 p. 98 illus., 76 illus. in color.  |b online resource. 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
347 |a text file  |b PDF  |2 rda 
520 |a Bisphosphonates are commonly prescribed to inhibit bone loss in patients with osteoporosis, as well as osteopenia, cancer, and Paget's disease of the bone. Recently, scientific literature has addressed a possible relationship between bisphosphonates and osteonecrosis of the jaw (ONJ). It is important to note that though the risks for developing ONJ are much higher for cancer patients on intravenous bisphosphonate therapy (used to reduce bone pain), the occurrence of ONJ also in patients treated with oral BF for osteoporosis has been also highlighted, though rarely. On the basis of the large use of BF, of their pharmacokinetics, of the systemic and local risk factors, physicians prescribing them and dental surgeons should be well informed on the various aspects of the problem. Aim of this volume is to offer an update on the current status of prevention, and on the current conservative and surgical treatments. The multidisciplinary approach will be very much appreciated by GP’s, the different specialists using bisphosphonates and by dental surgeons. 
650 0 |a Dentistry. 
650 0 |a Pharmacy. 
650 0 |a Medicine. 
650 0 |a General practice (Medicine). 
650 0 |a Radiology. 
650 0 |a Hematology. 
650 0 |a Oral surgery. 
650 0 |a Maxillofacial surgery. 
650 1 4 |a Medicine & Public Health. 
650 2 4 |a Oral and Maxillofacial Surgery. 
650 2 4 |a Dentistry. 
650 2 4 |a Hematology. 
650 2 4 |a General Practice / Family Medicine. 
650 2 4 |a Pharmacy. 
650 2 4 |a Imaging / Radiology. 
700 1 |a De Ponte, Francesco Saverio.  |e editor. 
710 2 |a SpringerLink (Online service) 
773 0 |t Springer eBooks 
776 0 8 |i Printed edition:  |z 9788847020825 
856 4 0 |u http://dx.doi.org/10.1007/978-88-470-2083-2  |z Full Text via HEAL-Link 
912 |a ZDB-2-SME 
950 |a Medicine (Springer-11650)